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OBJECTIVEdInformation on diabetes prevalence in the general population is scarce and
often based on extrapolations.We evaluatedwhether prevalence could be estimated from routine
data sources.
RESEARCHDESIGNANDMETHODSdThe sources were 1) hospital discharges (2008,
n = 828,171), 2) death registry (2007/2008, n = 118,659), and 3) Swiss Health Survey (SHS;
2007, n = 18,665). Persons without diabetes as underlying cause of death (death registry) or
principal diagnosis (hospital discharges) were regarded as surrogate for a general population
random sample.
RESULTSdIn those aged 20–84 years, 4.5% of men and 3% of women were expected to have
diabetes. By source, estimations were 4.4 and 2.8% (hospital discharges), 3.8 and 3.1% (death
registry), and 4.9 and 3.7% (SHS) for men and women, respectively. Among sources, age–sex
patterns were similar.
CONCLUSIONSdIn countries with adequate data quality, combination of routine data may
provide valid and reliable estimations of diabetes prevalence. Our figures suggest that Inter-
national Diabetes Federation extrapolations substantially overestimate diabetes prevalence in
Switzerland.
In most countries, information on di-abetes prevalence is scarce and, as inSwitzerland, often based on extrapola-
tions from other countries (1–5). We ex-
plored whether the combination of three
routine data sources (hospital discharges,
death registry, health survey) allows a
more valid prevalence estimation. We hy-
pothesize that in Switzerland diabetes re-
mains rarely undetected in inpatients
and that the risk of persons with diabetes
dying or being hospitalized for a reason
other than diabetes (e.g., accident, can-
cer) is approximately the same as that of
persons without diabetes. In that sense,
hospitalized or deceased persons with an-
other underlying cause/principal diagnosis
other than diabetes may be regarded as a
surrogate for a general population sam-
ple. In contrast, persons with diabetes as
an underlying cause/principal diagnosis
are likely to have a substantially increased
risk of hospitalization and death com-
pared with persons without diabetes and
should thus not be part of the surrogate
sample.
RESEARCH DESIGN AND
METHODS
Swiss Health Survey
The Swiss Health Survey (SHS) provides
nationally representative information
on the population aged $15 years (6).
Sampling is restricted to persons who
have a landline phone and who under-
stand a national language. In 2007,
18,665 (66%) people participated in the
interview. We defined diabetes with “Were
you ever told by a physician to have
diabetes?”
Hospital discharges
Inpatient hospital admissions in Switzerland
are routinely registered (7). Although
anonymous, hospitalizations of the same
individual can be merged. One principal
diagnosis (generally corresponding to the
main reason for hospitalization) and up
to 29 additional diagnoses (previously
known or detected during hospitalization)
are assessed, resulting in approximately 4
million diagnoses relating to 1.0 million
persons (2008). Diagnoses are coded ac-
cording to International Statistical Classifi-
cation of Diseases, 10th Revision (ICD-10;
Diabetes: E10–E14). We excluded indi-
viduals with principal diagnoses of ICD-
10 Chapters “Z,” “R,” and “O,” leaving
1,146,203 hospitalizations from 828,171
individuals with Swiss residence. Only
persons with diabetes as an additional
(but not principal) diagnosis were in-
cluded.
Death registry
In principle, the same concept was used
as for hospital discharges. Only persons
with diabetes as concomitant (but not
underlying) cause of death were included.
In Switzerland, death is certified by a
physician, including information on the
underlying cause and up to two concom-
itant diseases (8). By excluding ICD-10
Chapter “R,” 118,659 deaths in 2007–
2008 could be analyzed. For 28.3% of
these, one concomitant cause of death
was registered, and for 41.7%, two con-
comitant causes of death were registered.
It can be assumed that physicians’ di-
agnosis of diabetes in all three sources
was generally based on blood glucose
only (random $11.1 mmol/L or fasting
$7 mmol/L). Overall rates were age
standardized using the World Health
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Organization standard population
“Europe.” The number of individuals
with diabetes was obtained by multipli-
cation of age- and sex-specific prevalence
rates with the respective population
counts in 2008.
A Poisson regression model includ-
ing age, period, sex, and interaction of
sex and period was calculated to obtain
P values for increase in diabetes preva-
lence in 1995–2008 and for the difference
in increase between men and women.
RESULTS
SHS
In 2007, 4.9% of men and 3.7% of women
aged 20–84 years reported a diagnosis
of diabetes (Table 1). Prevalence peaked
in men aged 75–84 years (16.1%) and
women aged 85–94 years (12.0%). By
projecting these rates to the general popu-
lation aged 20–84 years in 2008, 279,000
people had diabetes.
Hospital discharges
Of 823,584 inpatients with principal di-
agnosis other than diabetes, there were
47,566 (5.8%) with diabetes as an addi-
tional diagnosis. Prevalence peaked at age
75–84 years (men: 14.8%, women: 11.1%).
By extrapolating prevalence rates to the
general population, 237,200 people had
diabetes.
Death registry
Among the 118,659 individuals with an
eligible underlying cause of death, a code
for diabetes was found in 12,018 (10.1%).
By limiting to diabetes coded exclusively
as concomitant disease, the maximal prev-
alence was 9.9% in men (aged 65–74
years) and 9.3% in women (aged 75–84
years). Extrapolating prevalence rates to
the general population resulted in 225,100
people with diabetes.
Trends
Death registry data showed a continuous
increase in diabetes prevalence in 1995–
2008 (P , 0.001 for both sexes), partic-
ularly in elderly persons and in men
(increase 1995–2008, men vs. women:
P , 0.001). A similar increase was also
suggested by the SHS (Supplementary
Fig. 1).
CONCLUSIONSdWhen no national
diabetes prevalence figures are available,
routine statistics from hospital dis-
charges, death registry, and health survey
can offer an alternative. The prevalence in T
ab
le
1d
Pr
op
or
ti
on
s
of
di
ab
et
es
an
d
ex
tr
ap
ol
at
ed
nu
m
be
r
of
pe
op
le
w
it
h
di
ab
et
es
in
Sw
it
ze
rl
an
d
by
se
x
ac
co
rd
in
g
to
th
re
e
di
ff
er
en
t
da
ta
so
ur
ce
s
D
at
a
so
u
rc
e
Ye
ar
W
it
h
di
ab
et
es
(n
)*
Pr
op
or
tio
n
w
it
h
di
ab
et
es
(%
)†
E
st
im
at
ed
w
it
h
di
ab
et
es
(n
)‡
M
en
W
om
en
T
ot
al
95
%
C
I
M
en
W
om
en
T
ot
al
A
ge
d
20
–
84
ye
ar
s,
po
p
ul
at
io
n
in
20
08
:5
.8
44
m
ill
io
n
1:
H
os
pi
ta
ld
is
ch
ar
ge
s,
ad
d
it
io
n
al
di
ag
no
si
s
20
08
41
,4
95
4.
4
2.
8
3.
6
3.
6–
3.
6
13
7,
00
0
10
0,
00
0
23
7,
00
0
2:
D
ea
th
re
gi
st
ry
,c
on
co
m
it
an
t
ca
us
e
20
07
/2
00
8
5,
87
7
3.
8
3.
1
3.
5
3.
4–
3.
6
11
6,
00
0
10
9,
00
0
22
5,
00
0
20
03
/2
00
4
5,
39
2
3.
4
2.
7
3.
1
3.
0–
3.
2
19
99
/2
00
0
5,
33
2
3.
1
2.
7
2.
9
2.
8–
3.
0
19
95
/1
99
6
4,
36
6
2.
3
2.
1
2.
2
2.
1–
2.
3
3:
SH
S,
ev
er
di
ag
n
os
ed
20
07
92
7
4.
9
3.
7
4.
3
4.
0–
4.
6
15
1,
00
0
12
8,
00
0
27
9,
00
0
20
02
79
1
4
3.
2
3.
6
3.
3–
3.
9
19
97
39
6
3.
5
2.
9
3.
2
2.
9–
3.
5
1–
3:
C
om
bi
n
at
io
n
of
th
e
th
re
e
da
ta
so
ur
ce
s
20
07
/2
00
8
3.
8–
4.
9
2.
8–
3.
7
3.
5–
4.
3
11
6,
00
0–
15
1,
00
0
10
0,
00
0–
12
8,
00
0
22
5,
00
0–
27
9,
00
0
A
ge
d
0–
19
an
d
85
+
ye
ar
s,
po
p
ul
at
io
n
in
20
08
:1
.8
04
m
ill
io
n
1:
H
os
pi
ta
ld
is
ch
ar
ge
s,
ad
d
it
io
n
al
di
ag
no
si
s
20
08
7,
00
0
13
,0
00
20
,0
00
A
ll
ag
es
,p
op
ul
at
io
n
in
20
08
:7
.6
48
m
ill
io
n
1–
3:
C
om
bi
n
at
io
n
of
th
e
th
re
e
da
ta
so
ur
ce
s
12
3,
00
0–
15
8,
00
0
11
3,
00
0–
14
1,
00
0
24
5,
00
0–
29
9,
00
0
*I
n
th
e
st
u
dy
po
p
ul
at
io
n
(m
en
an
d
w
om
en
).
†
A
ge
st
an
da
rd
iz
ed
.‡
In
th
e
ge
ne
ra
lp
op
ul
at
io
n.
2 DIABETES CARE care.diabetesjournals.org
Diabetes prevalence in Switzerland
Switzerland can be estimated at 3.5–4.3%,
corresponding to 245,000–300,000 peo-
ple with diabetes. The age–sex patterns
were strikingly similar among the three
data sources (Supplementary Fig. 1), e.g.,
a higher prevalence in men in virtually all
age classes.
Our approach underestimates rather
than overestimates diabetes prevalence.
For inpatients, the proportion of undiag-
nosed diabetes is expected to be small.
However, individuals with the highest
risk of diabetes were not included in our
analysis because these persons are likely
to be hospitalized with diabetes as a
principal instead of only additional di-
agnosis. In the death registry, multimor-
bidity may cause increased “competition”
of mentions of concomitant causes of
death in decedents aged $65 years, with
diabetes not being mentioned in favor
of other concomitant conditions. In ad-
dition, diabetes may not be captured in
sudden deaths. Self-reporting individuals
in the SHSmay not be aware of the disease
(9–12). From all three sources, underes-
timation could also be expected because
an oral glucose tolerance test is not rou-
tinely administered in a clinical setting.
Some overestimation of our figures could
be expected because of the generally in-
creased morbidity and mortality of dia-
betic patients increasing their likelihood
of hospitalization and death also due to
other conditions or a tendency of study
participants to overreport disease (13).
Published extrapolations of diabetes
prevalence in Switzerland in 2010 sug-
gested higher figures than our estima-
tions: 350,000–630,000 (2–5). For 2010,
the International Diabetes Federation
predicted a number twice as high as our
highest estimate, implying one of the
highest prevalence rates in the Western
world (2). Accordingly, Switzerland would
have a higher diabetes prevalence than
countries with a three times higher obesity
prevalence and markedly higher cardio-
vascular disease mortality (14). Therefore,
even considering the maximum extent of
potential underestimation arising from
our approach, our estimates appear more
realistic. In fact, our highest estimates for
Switzerland were in line with 2010 figures
for European countries with a low preva-
lence of diabetes, such as France, Belgium,
the Netherlands, and Sweden, and still
somewhat higher than those for the U.K.
(2,12), but definitively lower than those
from neighboring Germany (2,9,15). In
Switzerland, a proportion of undiagnosed
diabetes can be expected to be similar to
that of France (i.e., 20%), and a part of
the increase in diabetes prevalence may
relate to decreasing proportions of un-
diagnosed cases (12). Nevertheless, the
magnitude of the increase in diabetes
prevalence in 1995–2008 suggests that
diabetes prevention should be reinforced
in Switzerland, particularly in men.
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